Skip to main content
Svas Biosana logo

Svas Biosana — Investor Relations & Filings

Ticker · SVS ISIN · IT0005469264 LEI · 81560055A88E1D16D537 XMIL Manufacturing
Open in API
Filings indexed 284 across all filing types
Latest filing 2022-09-30 Transaction in Own Shar…
Country IT Italy
Listing XMIL SVS

About Svas Biosana

https://svas.it/en/

Svas Biosana is a company that specializes in the planning, manufacturing, and distribution of medical devices and pharmaceutical products. The company's portfolio includes a range of disposable hospital supplies, such as incontinence aids and traditional dressings. Serving both public and private health institutions, Svas Biosana develops, produces, and distributes its own branded products as well as those from third-party manufacturers.

Recent filings

Filing Released Lang Actions
Acquisto azioni proprie
Transaction in Own Shares Classification · 99% confidence The document is titled "INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE" (Weekly Information on Own Share Purchase) and explicitly states that the company acquired a specific number of its own shares during the period from September 26 to September 30, 2022. This directly corresponds to the definition of a Transaction in Own Shares (share repurchase/issuance). The filing code for this activity is POS.
2022-09-30 Italian
Approvazione Bilancio consolidato intermedio al 30.06.2022
Earnings Release Classification · 95% confidence The document is a press release (COMUNICATO STAMPA) announcing that the Board of Directors approved the 'relazione finanziaria semestrale consolidata al 30 giugno 2022' (consolidated semi-annual financial report as of June 30, 2022). It provides key financial highlights (Revenue, EBITDA, Net Income) for the first half of the year (1H/2022). This content structure—a formal announcement summarizing the results of a mandated periodic report—is characteristic of an Earnings Release (ER). However, since it explicitly mentions the approval of the 'relazione semestrale consolidata' (which is a comprehensive report for a period shorter than a year), it aligns most closely with the definition of an Interim / Quarterly Report (IR), or the announcement thereof. Given the detailed financial tables and commentary, it serves as the primary release of the period's results, which is the function of an Earnings Release (ER). Furthermore, the text explicitly states that the full 'relazione semestrale' will be made available later, suggesting this document is the initial summary announcement. The key financial figures cover the period ending June 30, 2022, making it a semi-annual/interim report summary. I will classify it as an Earnings Release (ER) as it is the initial public announcement of the period's results, even though the underlying document is the semi-annual report. H1 2022
2022-09-26 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 99% confidence The document is titled "INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE" (Weekly Information on Own Share Purchase) and details the number of shares purchased by the company (Svas Biosana S.p.A.) during a specific weekly period (September 19 to September 23, 2022). This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The filing code for this is POS.
2022-09-23 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 98% confidence The document is titled "INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE" (Weekly Information on Own Share Purchase) and the subject line is "Acquisto azioni proprie" (Purchase of own shares). It details the number of shares purchased, the average price, and the total consideration for the period from September 12 to September 16, 2022, as part of an authorized share buyback program. This activity directly corresponds to the definition of a company reporting transactions involving its own shares, which maps to the 'Transaction in Own Shares' category (POS). Although it is a weekly report, the core subject matter is the repurchase activity itself, not just an announcement of a report release.
2022-09-16 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 98% confidence The document is titled 'INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE' (Weekly Information on Own Share Purchase) and details the number of shares the company purchased during the period from September 5 to September 9, 2022. This activity falls directly under the definition of a company reporting transactions involving its own shares. The specific filing category for this is 'Transaction in Own Shares' (POS). Although it is a regulatory filing (indicated by the 'Informazione Regolamentata' header), POS is the most specific category available for share repurchase/issuance reports.
2022-09-09 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 98% confidence The document is titled 'INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE' (Weekly Information on Own Share Purchase) and the 'Oggetto' (Subject) is 'Acquisto azioni proprie' (Purchase of own shares). It details the number of shares bought back by the company (Svas Biosana S.p.A.) during a specific weekly period (August 29, 2022, to September 2, 2022). This activity directly corresponds to the definition of a company buying back or selling its own shares, which is classified as 'Transaction in Own Shares' (POS). Although it is a regulatory filing (indicated by the 'Informazione Regolamentata' header), the specific nature of the content points directly to POS over the general RNS category.
2022-09-02 Italian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.